Eli Lilly had its Relative Strength (RS) Rating upgraded from 69 to 79 Monday -- a welcome improvement, but still below the 80 or better score you prefer to see.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the best stocks often have an RS Rating of over 80 as they begin their largest price moves. See if Eli Lilly can continue to rebound and clear that threshold.
Looking For Winning Stocks? Try This Simple Routine
Eli Lilly is not currently near a potential buying area, having fallen below a recent flat base. See if the stock goes on to build a chart pattern that could launch a new move.
The company reported negative growth for both sales and earnings last quarter.
The company holds the No. 2 rank among its peers in the Medical-Diversified industry group. Danaher is also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
